Immuron Limited IMRN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • AU • USD

SharesGrow Score

46/100

1/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Immuron Limited (IMRN) has a negative trailing P/E of -1.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -62.80%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -1.6); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -62.80%).
Trailing Earnings Yield -62.80% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 45/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

46/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✓

FUTURE

100/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

41/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — IMRN

Valuation Multiples

P/E (TTM)-1.6

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.57

P/S Ratio0.93

EV/EBITDA0.6

Per Share Data

EPS (TTM)$-0.02

Book Value / Share$0.05

Revenue / Share$0.03

FCF / Share$-0.02

Yields & Fair Value

Earnings Yield-62.80%

Dividend Yield0.00%

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2016	-3.0	-0.02	4.34	21.44	-
2017	-4.3	0.14	4.50	21.17	-
2018	-15.2	0.23	5.43	24.87	-
2019	-3.2	-0.07	2.04	6.29	-
2020	-16.2	0.33	8.41	18.84	-
2021	-4.3	-0.03	1.38	245.08	-
2022	-6.2	0.09	0.76	23.05	-
2023	-4.6	-0.14	0.88	9.57	-
2024	-2.8	-0.03	1.52	3.94	-
2025	-2.9	0.11	1.90	2.09	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-3.70	$1M	$-7.07M	-706.1%
2017	$-2.57	$1.4M	$-6.8M	-487.3%
2018	$-0.90	$1.84M	$-3.01M	-163.4%
2019	$-1.29	$2.39M	$-4.66M	-195%
2020	$-0.66	$2.52M	$-2.93M	-116.2%
2021	$-1.52	$145.78K	$-8.38M	-5751.6%
2022	$-0.50	$765.19K	$-2.85M	-373%
2023	$-0.66	$1.8M	$-3.79M	-209.8%
2024	$-1.22	$4.9M	$-6.94M	-141.5%
2025	$-0.90	$7.29M	$-5.22M	-71.6%